Facultad de Enfermería y Fisioterapia Salus Infirmorum

Propolis nasal spray effectively improves recovery from infectious acute rhinitis and common cold symptoms in children: a pilot study / (Record no. 13110)

MARC details
000 -LEADER
fixed length control field 02326nas a22002657a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20210421161430.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m|||||r|||| 00| 0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field ta
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 171219t2017 sp ||||| |||| 00| 0 spa |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0393-974X
040 ## - CATALOGING SOURCE
Transcribing agency Salus Infirmorum
245 00 - TITLE STATEMENT
Title Propolis nasal spray effectively improves recovery from infectious acute rhinitis and common cold symptoms in children: a pilot study /
Statement of responsibility, etc. Marti J; López F; Gascón I; Julve J
500 ## - GENERAL NOTE
General note PDF en biblioteca
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Bibliografía: 949-950
520 8# - SUMMARY, ETC.
Summary, etc. Currently, treatment for acute rhinitis (AR) is symptomatic but no clear agreement exists to control its development. Propolis extract may appear as a promising natural treatment for AR, but its beneficial effects have not yet been fully tested. Forty children suffering from AR and common cold symptoms aged between 2-12 years were enrolled in a prospective epidemiological multicentre study. A 7-day treatment with propolis nasal spray (3 times/day) was applied and a comparison of symptomatology, subjective global improvement and quality of life (QoL) between baseline (day 1) and final (day 7) visits were performed. The main goal was to evaluate the changes in symptom intensity using the Jackson’s scoring test. After 7 days of treatment there was a significant decrease of symptoms both in the total score (p < 0.0001) and in regard to each AR symptom (p < 0.01). On the whole, the sample reported no symptoms by day 7, and the resolution of symptoms occurred approximately at day 4. Furthermore, there was no <br/>need for supplementary treatment. Both the subjective global improvement impression and the QoL of patients appeared to significantly improve after treatment. No adverse events (AEs) were found globally. <br/>It can be concluded that propolis nasal spray effectively improves recovery from infectious AR and common cold symptoms in children and is an optimal alternative in the treatment of this disease without need for any adjuvant treatment.
653 14 - INDEX TERM--UNCONTROLLED
Uncontrolled term propolis
653 14 - INDEX TERM--UNCONTROLLED
Uncontrolled term acute rhinitis
653 14 - INDEX TERM--UNCONTROLLED
Uncontrolled term cold
653 14 - INDEX TERM--UNCONTROLLED
Uncontrolled term effectiveness
653 14 - INDEX TERM--UNCONTROLLED
Uncontrolled term quality of life
653 14 - INDEX TERM--UNCONTROLLED
Uncontrolled term children
773 ## - HOST ITEM ENTRY
Related parts -- 2017, v. 31, 4, p. 943-950
Title Journal of biological regulators and homeostatic agents
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Universal Decimal Classification
Koha item type Artículo de revista
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    Universal Decimal Classification     Non-fiction Revistas y artículos Revistas y artículos 21/04/2021   PP 5751 21/04/2021 21/04/2021 Artículo de revista

Powered by Koha